Cingulate Inc. entered into an ATM Sales Agreement with A.G.P./Alliance Global Partners on March 24, 2026, to offer and sell up to $100,000,000 of common stock through at-the-market offerings. At the Special Meeting on the same date, stockholders approved the issuance of common stock upon conversion of Series A Convertible Preferred Stock and exercise of warrants for Nasdaq compliance.
Key takeaways
ATM Sales Agreement dated March 24, 2026, with A.G.P./Alliance Global Partners for aggregate gross proceeds up to $100,000,000.
A.G.P. commission of 3.0% on aggregate gross proceeds from Placement Shares sold.
Sales through at-the-market offerings on Nasdaq Capital Market pursuant to Registration Statement File No. 333-292680.
Special Meeting Proposal 1 approved: 2,758,323 For, 97,941 Against, 12,372 Abstain, 0 Broker Non-Votes.
Proposal 1 approves issuance for Nasdaq Listing Rule 5635(b) compliance related to January 27, 2026 securities purchase agreement.
Proposal 2 for adjournment approved but deemed unnecessary: 2,739,924 For, 116,691 Against, 12,021 Abstain.